Metabolic risk factors associated with serum creatinine in a non-diabetic population

被引:0
作者
Jens Kronborg
Trond Jenssen
Inger Njølstad
Ingrid Toft
Bjørn O. Eriksen
机构
[1] University of Tromsø,Institute of Clinical Medicine
[2] Innlandet Hospital Trust,Department of Internal Medicine
[3] Lillehammer,Department of Nephrology
[4] Rikshospitalet University Hospital,Institute of Community Medicine
[5] University of Tromsø,Department of Nephrology
[6] University Hospital of North Norway,Clinical Research Center
[7] University Hospital of North Norway,undefined
来源
European Journal of Epidemiology | 2007年 / 22卷
关键词
Albuminuria; Creatinine; Cross-sectional studies; HDL-cholesterol; Insulin resistance; Metabolic syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
Insulin resistance, low HDL-cholesterol and microalbuminuria are important components of the metabolic syndrome as defined by WHO. Insulin resistance and low HDL-cholesterol are also common in chronic kidney disease (CKD), but it is not clear whether they are early or late phenomenons in the development of renal failure. This study examined whether low-grade albuminuria (microalbuminuria), lipoprotein fractions, and the insulin/glucose ratio (IGR)—a surrogate marker of insulin resistance—were related to renal function (expressed as serum creatinine) in persons without diabetes and with apparently normal renal function. The study included 4,131 men and women aged 55–75 years from the cross-sectional Tromsø IV survey (1994–1995). Lifestyle factors, waist circumference and blood pressure were included in the analyses. Gender stratified multivariate analysis was used to assess the relationship between serum creatinine and microalbuminuria, lipoprotein fractions and IGR. Serum creatinine was positively associated with microalbuminuria in men (β = 2.50, 95% confidence interval (CI) 0.66–4.34), but not in women. HDL-cholesterol and IGR were strongly associated with creatinine in both genders (HDL-cholesterol: Men: β = −4.82, 95% CI −6.27 to −3.37; women: β = −2.12, 95% CI −3.28 to −0.96. IGR: Second, third and fourth quartile compared with first quartile, men: β = 0.94, 95% CI −0.63 to 2.51; 2.10, 95% CI 0.52–3.69 and 2.40, 95% CI 0.75–4.04; women: β = 1.91, 95% CI 0.59–3.22; 2.61, 95% CI 1.28–3.95 and 3.20, 95% CI 1.80–4.60). These findings suggest that even early impairment of renal function may be associated with insulin resistance and dyslipidemia, regardless of renal albumin leakage.
引用
收藏
页码:707 / 713
页数:6
相关论文
共 50 条
[41]   Different risk factors and causes for early death after initiating dialysis in diabetic and non-diabetic patients [J].
Biesenbach, Georg ;
Loipl, Johann ;
Schmekal, Bernhard ;
Janko, Otmar .
RENAL FAILURE, 2007, 29 (01) :49-53
[42]   Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients [J].
Al-Daghri, Nasser M. ;
Al-Attas, Omar S. ;
Wani, Kaiser ;
Sabico, Shaun ;
Alokail, Majed S. .
SCIENTIFIC REPORTS, 2017, 7
[43]   Comparison of novel markers of metabolic complications and cardiovascular risk factors between obese non-diabetic and obese type 1 diabetic children and young adults [J].
Kacka, Anna ;
Charemska, Anna ;
Jarocka-Cyrta, Elzbieta ;
Glowinska-Olszewska, Barbara .
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[44]   Prevalence of metabolic syndrome and its determinants in older Mexican non-diabetic adults [J].
Aleman-Mateo, Heliodoro ;
Lopez Teros, Miriam T. ;
Urquidez-Romero, Rene ;
Huesca, Luis .
NUTRICION HOSPITALARIA, 2018, 35 (02) :294-304
[45]   Sociodemographic risk factors associated with metabolic syndrome in a Mediterranean population [J].
Buckland, Genevieve ;
Salas-Salvado, Jordi ;
Roure, Eulalia ;
Bullo, Monica ;
Serra-Majem, Lluis .
PUBLIC HEALTH NUTRITION, 2008, 11 (12) :1372-1378
[46]   Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals [J].
Son, Jang-Won ;
Kim, Mee-Kyoung ;
Park, Yong-Moon ;
Baek, Ki-Hyun ;
Yoo, Soon-Jib ;
Song, Ki-Ho ;
Son, Hyun Shik ;
Yoon, Kun-Ho ;
Lee, Won Chul ;
Cha, Bong-Yun ;
Son, Ho-Young ;
Kwon, Hyuk-Sang .
ENDOCRINE JOURNAL, 2011, 58 (01) :39-46
[47]   Does Microalbuminuria Affect Resistin and Cardiometabolic Risk Factors in Hypertensive Non-Diabetic Females? [J].
Ulu, Sena ;
Gursoy, Gul ;
Demirbas, Berrin ;
Acar, Yasar ;
Cimbek, Ahmet ;
Dal, Hayriye Cankar ;
Bayram, Murat .
HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2014, 52 (03) :172-176
[48]   Serum CD14 concentration is associated with obesity and insulin resistance in non-diabetic individuals [J].
Kang, Yea Eun ;
Joung, Kyong Hye ;
Kim, Ji Min ;
Lee, Ju Hee ;
Kim, Hyun Jin ;
Ku, Bon Jeong .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (10)
[49]   Observations on factors that influence thyroid nodules in diabetic and non-diabetic patients in the Zhejiang province of China [J].
Tu, Weiping ;
Zhang, Gengsheng ;
Yu, Shuifen ;
Tang, Jimei ;
Yu, Jiangsu .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10) :19332-19338
[50]   Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population [J].
B. Fagerberg ;
S. Edwards ;
T. Halmos ;
J. Lopatynski ;
H. Schuster ;
S. Stender ;
G. Stoa-Birketvedt ;
S. Tonstad ;
S Halldórsdóttir ;
I. Gause-Nilsson .
Diabetologia, 2005, 48 :1716-1725